3 Stocks I’m Buying Till I’m Blue in the Face

Tech stocks like Constellation Software (TSX:CSU) are on my shopping list.

| More on:

Besides energy and commodities, nearly every sector has dropped this year. The S&P/TSX Composite Index is down 4.5% year to date. That masks the utter destruction in sectors such as technology and consumer retail. Many of these stocks have lost half their value or more this year, which signifies a deep bear market

This is precisely the time for some bargain hunting. Here are the top three stocks I’m buying till I’m blue in the face. 

WELL Health

I first bought WELL Health (TSX:WELL) in early 2020. Since then, a lot has changed, but one thing remains the same: WELL’s attractiveness as an investment. 

Over the past two years, the company has raised capital from noteworthy investors, including billionaire Li Ka Shing. These funds have been used to add new services (such as telehealth) and expand to new locations (such as the U.S.)

The stock has surged nearly every year since it was listed in 2016. However, 2022 was different. It’s down 42% year to date. Investors seem really reluctant to invest in a small-cap stock that’s still seen as a tech beneficiary of the pandemic. I’ve been buying more on the bet that this company is much more than that. 

I believe digitizing healthcare in the developed world, particularly in North America, is incredibly enticing. It’s a trillion-dollar opportunity in the U.S. alone, where WELL Health has seen triple-digit gains. However, private healthcare tech also has potential in Canada where major provinces like Alberta and Ontario are moving towards healthcare privatization. 

Meanwhile, the stock is undervalued. It’s trading at just six to seven times EBITDA (earnings before interest, taxes, depreciation, and amortization) and just 1.2 times revenue. That’s why I’m snapping up much more. 

Constellation Software

Constellation Software (TSX:CSU) is my other top pick. I started accumulating this stock earlier in 2022. After all, this stock is rarely on discount. I simply couldn’t resist. 

Constellation has lost 9.4% of its value year to date. That’s more than double the loss of the benchmark index. The enterprise tech giant is another victim of the ongoing tech selloff this year. However, it’s nothing like its money-losing consumer tech peers. Instead, half the company’s revenue is generated from government contracts, and cash flow has been positive for decades. 

Constellation’s key growth driver — acquisitions — have been ramped up this year. That’s why I expect the company to achieve higher growth and profits in 2023 and beyond. Right now, it’s still undervalued, in my opinion. 

MDA

Space tech stock MDA (TSX:MDA) is an unlikely candidate on this list. In the midst of inflation and rising interest rates, the budget for rockets and satellites is far from certain. However, two key events prompted me to add exposure to this stock in 2022. 

Firstly, the latest iPhone included Emergency SOS via Satellite technology. The system operates on a constellation of satellites that are being manufactured by MDA. The contract to supply 17 new satellites for the service by 2025 is worth US$327 million (CA$444 million) and is already funded 95%. 

Secondly, NASA successfully launched the first Artemis mission to the moon this month. So far, it’s meeting all its targets. MDA is under contract to develop Canadarm 3 for the Artemis II mission that follows. 

These two events indicate that the space tech industry is already mature. The long lead times for these projects make them somewhat immune to short-term economic cycles. In other words, MDA should experience growth in 2023 even if the economy craters. That’s why I’m buying more. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has positions in Constellation Software, Topicus.com, and Well Health Technologies. The Motley Fool has positions in and recommends Topicus.com. The Motley Fool recommends Constellation Software. The Motley Fool has a disclosure policy.

More on Investing

chart reflected in eyeglass lenses
Tech Stocks

Top Canadian AI Stocks to Watch in 2025

Celestica (TSX:CLS) stock and another Canadian AI stock are worth watching closely this holiday season.

Read more »

woman looks out at horizon
Investing

Is Sun Life Financial Stock a Buy for its 4% Dividend Yield?

Let's dive into whether Sun Life Financial (TSX:SLF) stock is a buy for its dividend yield alone, or if this…

Read more »

Pumpjack in Alberta Canada
Energy Stocks

1 Magnificent Energy Stock Down 17% to Buy and Hold Forever

Down over 17% from all-time highs, Headwater Exploration is a TSX energy stock that offers you a tasty dividend yield…

Read more »

Man data analyze
Investing

Want $1 Million in Retirement? 2 Simple Index Funds to Buy and Hold for Decades

Just invest in a S&P 500 index fund and do nothing.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, November 21

Escalating geopolitical tensions and U.S. economic data remain on investors’ radar today as the TSX continues to hover above the…

Read more »

think thought consider
Investing

Should You Buy Couche-Tard Stock Aggressively Before Nov. 25?

Here’s what could help Couche-Tard stock rebound after its upcoming earnings event.

Read more »

calculate and analyze stock
Bank Stocks

4% Dividend Yield? I Keep Buying This Dividend Stock in Bulk!

If you find the perfect dividend stock, you never have to worry about investing again. And that's what you get…

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Should You Buy the 3 Highest-Paying Dividend Stocks in Canada?

A few dividend stocks saw a sharp correction in November, increasing their yields. Are they a buy for high dividends?

Read more »